Kathryn White

2.0k total citations
38 papers, 1.3k citations indexed

About

Kathryn White is a scholar working on Molecular Biology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Kathryn White has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Rheumatology and 8 papers in Organic Chemistry. Recurrent topics in Kathryn White's work include Folate and B Vitamins Research (10 papers), Biochemical and Molecular Research (8 papers) and Cancer therapeutics and mechanisms (8 papers). Kathryn White is often cited by papers focused on Folate and B Vitamins Research (10 papers), Biochemical and Molecular Research (8 papers) and Cancer therapeutics and mechanisms (8 papers). Kathryn White collaborates with scholars based in United States, China and Italy. Kathryn White's co-authors include Juiwanna Kushner, Lisa Polin, Thomas H. Corbett, Jerome P. Horwitz, Stuart Hazeldine, Aleem Gangjee, Larry H. Matherly, Zhanjun Hou, Jeffrey W. Taub and Holly Edwards and has published in prestigious journals such as Annals of Internal Medicine, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Kathryn White

37 papers receiving 1.3k citations

Peers

Countries citing papers authored by Kathryn White

Since Specialization

Citations

This map shows the geographic impact of Kathryn White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn White more than expected).

Fields of papers citing papers by Kathryn White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn White. The network helps show where Kathryn White may publish in the future.

Co-authorship network of co-authors of Kathryn White

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn White. A scholar is included among the top collaborators of Kathryn White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn White. Kathryn White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress 2025 ·Journal of Experimental & Clinical Cancer Research ·Jenna L. Carter, Yongwei Su, (unknown), Jianlei Zhao, (unknown), Guan Wang, Holly Edwards, Lisa Polin, Juiwanna Kushner, (unknown), Kathryn White, Steven Buck, Maik Hüttemann, Joshua E. Allen, (unknown), Jay Yang, Jeffrey W. Taub, Yubin Ge	0
2	Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review 2023 ·Cureus ·(unknown), Kathryn White, John Campbell, (unknown), (unknown), (unknown), Shahab Ahmadzadeh, Giustino Varrassi, Sahar Shekoohi, Alan D. Kaye	6
3	The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML 2021 ·Blood Cancer Journal ·(unknown), Jun Ma, Tristan Knight, Yongwei Su, Holly Edwards, Lisa Polin, Jing Li, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jian Wang, Hai Lin, Yue Wang, (unknown), Guan Wang, Jeffrey W. Taub, Yubin Ge	27
4	Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia 2020 ·Signal Transduction and Targeted Therapy ·Daniel A Luedtke, Yongwei Su, Jun Ma, Xinyu Li, Steven Buck, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Hai Lin, Jeffrey W. Taub, Yubin Ge	50
5	Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation 2020 ·Cancers ·Fangbing Liu, Hasini A. Kalpage, (unknown), Holly Edwards, Maik Hüttemann, Jun Ma, Yongwei Su, Jenna L. Carter, Xinyu Li, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Guan Wang, Jeffrey W. Taub, Yubin Ge	29
6	The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia 2020 ·Haematologica ·Xinyu Li, Yongwei Su, (unknown), Gerard J. Madlambayan, Holly Edwards, Tristan Knight, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jay Yang, (unknown), Guan Wang, Lijing Zhao, Y. Lynn Wang, (unknown), Jeffrey W. Taub, Yubin Ge	38
7	Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia 2019 ·Clinical Cancer Research ·Jun Ma, (unknown), (unknown), Tristan Knight, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Guan Wang, Lijing Zhao, Hai Lin, Yue Wang, Jeffrey W. Taub, Yubin Ge	117
8	Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates 2017 ·Molecular Cancer Therapeutics ·Zhanjun Hou, (unknown), (unknown), Yang Si, Adrianne Wallace-Povirk, (unknown), (unknown), Lisa Polin, Kathryn White, Juiwanna Kushner, Robert Morris, Aleem Gangjee, Larry H. Matherly	38
9	6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors 2015 ·Journal of Medicinal Chemistry ·Lei Wang, Adrianne Wallace-Povirk, Sudhir Raghavan, (unknown), Mike R. Wilson, Si Yang, Lisa Polin, Kathryn White, Juiwanna Kushner, (unknown), (unknown), (unknown), Zhanjun Hou, (unknown), Charles E. Dann, Larry H. Matherly, Aleem Gangjee	35
10	Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter 2013 ·Cancer Chemotherapy and Pharmacology ·Christina Cherian, Sita Kugel Desmoulin, Lei Wang, Lisa Polin, Kathryn White, Juiwanna Kushner, Mark Stout, Zhanjun Hou, Aleem Gangjee, Larry H. Matherly	20
11	Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter 2012 ·Molecular Pharmacology ·Sita Kugel Desmoulin, Lei Wang, Lisa Polin, Kathryn White, Juiwanna Kushner, Mark Stout, Zhanjun Hou, Christina Cherian, Aleem Gangjee, Larry H. Matherly	27
12	Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter 2011 ·Molecular Pharmacology ·Sita Kugel Desmoulin, Lei Wang, (unknown), Lisa Polin, Kathryn White, Juiwanna Kushner, Mark Stout, Zhanjun Hou, Christina Cherian, Aleem Gangjee, Larry H. Matherly	57
13	Synthetic modification of the 2-oxypropionic acid moiety in 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469), and consequent antitumor effects. Part 4 2005 ·Bioorganic & Medicinal Chemistry ·Stuart Hazeldine, Lisa Polin, Juiwanna Kushner, Kathryn White, Thomas H. Corbett, Jerome P. Horwitz	22
14	Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5 2005 ·Bioorganic & Medicinal Chemistry ·Stuart Hazeldine, Lisa Polin, Juiwanna Kushner, Kathryn White, Thomas H. Corbett, Jerome P. Horwitz	21
15	Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors 2003 ·Cancer Chemotherapy and Pharmacology ·Ramesh Boinpally, Lisa Polin, Sen-Lin Zhou, Bhaskara Jasti, Richard Wiegand, Kathryn White, Juiwanna Kushner, Jerome P. Horwitz, Thomas H. Corbett, Ralph E. Parchment	6
16	Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169 2003 ·Investigational New Drugs ·Thomas H. Corbett, Kathryn White, Lisa Polin, Juiwanna Kushner, (unknown), Chuan Shih, (unknown)	23
17	Preclinical Efficacy Evaluations of XK-469: Dose Schedule, Route and Cross-Resistance Behavior in Tumor Bearing Mice 2002 ·Investigational New Drugs ·Lisa Polin, Kathryn White, Juiwanna Kushner, (unknown), (unknown), Susan Pugh, (unknown), Stuart Hazeldine, Joseph A. Fontana, Patricia LoRusso, Jerome P. Horwitz, Thomas H. Corbett	13
18	Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate 1998 ·Investigational New Drugs ·Thomas H. Corbett, Patricia LoRusso, (unknown), (unknown), Susan Pugh, Kathryn White, Juiwanna Kushner, Lisa Polin, Jennifer Meyer, (unknown), Lance K. Heilbrun, Jerome P. Horwitz, Janet L. Gross, Carl H. Behrens, Barbara Harrison, R. J. McRipley, George L. Trainor	55
19	Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice 1997 ·Investigational New Drugs ·Lisa Polin, Frederick A. Valeriote, Kathryn White, (unknown), Susan Pugh, (unknown), Patricia LoRusso, Maha Hussain, (unknown), (unknown), (unknown), Gregory M. L. Patterson, Richard E. Moore, Thomas H. Corbett	41
20	Discovery of cryptophycin-1 and BCN-183577: Examples of strategies and problems in the detection of antitumor activity in mice 1997 ·Investigational New Drugs ·Thomas H. Corbett, Frederick A. Valeriote, Lisa Demchik, (unknown), Lisa Polin, (unknown), Susan Pugh, Kathryn White, Juiwanna Kushner, James Rake, Mark P. Wentland, Trimurtulu Golakoti, (unknown), (unknown), Gregory M. L. Patterson, Richard E. Moore	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact